Owkin
Saramony Lebasnier is an experienced professional in regulatory affairs and quality assurance, currently serving as the Senior Regulatory Affairs & Quality Assurance Manager at Owkin since September 2022. Previously, Saramony held the position of Global Regulatory Affairs Manager for Medical Device Software and AI at Guerbet from May 2020 to September 2022, focusing on digital products. At Mauna Kea Technologies, from August 2014 to May 2020, Saramony undertook roles including Data Protection Officer and Software Regulatory Engineer, managing software regulatory analysis for Cellvizio products and ensuring compliance with EU & US standards. Earlier experience includes project management and leadership roles in R&D at Agfa Healthcare from March 2005 to July 2014, covering various software development projects and team management. Saramony's educational background includes a Master's degree in Sciences and Technologies for Information and Communication from Nice–Sophia Antipolis University and multiple degrees in Mathematics and Computer Science. Specialties include medical software, artificial intelligence, and cybersecurity.
This person is not in any teams
This person is not in any offices
Owkin
6 followers
Owkin believes that medical research should be collaborative, inclusive, and privacy-preserving. Today, Owkin is pioneering AI in healthcare. It leverages its collaborative federated learning software and expert AI capabilities to bring solutions to optimize drug development and improve patient care in oncology. Owkin’s work has been published in Nature Medicine and other top-tier journals. Owkin has raised over $70M from leading VC funds and is now working with the most prominent cancer centers and pharmaceutical companies in Europe and the US. Additionally, Owkin leads several federated learning consortia, including; MELLODDY, to facilitate 'co-opetive' drug discovery between pharma companies, and Healthchain, to allow collaborative research across multiple hospitals. Owkin was co-founded in 2016 by Thomas Clozel, MD, a clinical research doctor and former assistant professor in clinical hematology, and by Gilles Wainrib, Ph.D., an academic pioneer in the field of Artificial Intelligence in biology.